Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be the main focused R&D centre and also is the origin country of Alphapharm.

Alphapharm was founded in 1982. Alphapharm pioneers in the pharmaceutical company, dedicated to advancing global healthcare through innovation. The company focus on oncology, neurology, cardiovascular health, and infectious diseases, offering a diverse range of high-quality medications.

Do read about some of the most popular patents of Alphapharm which have been covered by us in this article and also you can find Alphapharm patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alphapharm patent portfolio.

How many patents does Alphapharm have?

Alphapharm has a total of 108 patents globally. These patents belong to 15 unique patent families. Out of 108 patents, 20 patents are active.

How Many Patents did Alphapharm File Every Year?

Alphapharm Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAlphapharm Applications FiledAlphapharm Patents Granted
201712
2016213
201519
2014213
2013104
20112
20102
2009212
200827
200735

How many Alphapharm patents are Alive/Dead?

Worldwide Patents

Alphapharm Patent Portfolio

How Many Patents did Alphapharm File in Different Countries?

Alphapharm Worldwide Patent Filing

Countries in which Alphapharm Filed Patents

CountryPatent
Australia18
Europe (EPO)13
United States of America11
Canada11
Japan7
India6
China5
New Zealand3
Spain2
Slovenia2
Austria2
Germany2
Estonia2
Malta2
Portugal1
South Africa1
Slovakia1
Croatia1
Hungary1
Poland1
Cyprus1
Denmark1
Norway1

Where are Research Centers of Alphapharm Patents Located?

R&D Centres of Alphapharm

10 Best Alphapharm Patents

WO2008095263A1 is the most popular patent in the Alphapharm portfolio. It has received 32 citations so far from companies like Novartis, Omeros Corp, Eli Lilly.

Below is the list of 10 most cited patents of Alphapharm:

Publication NumberCitation Count
WO2008095263A132
US20150175282A120
WO2008000040A117
WO2007053904A116
CN101939004A10
WO2009049354A19
WO2008074098A18
WO2009026621A17
WO2007121523A15
US20110206770A14

What are Alphapharm key innovation segments?

What Technologies are Covered by Alphapharm?

The chart below distributes patents filed by Alphapharm in different countries on the basis of the technology protected in patents. It also represents the markets where Alphapharm thinks it’s important to protect particular technology inventions.

R&D Focus: How has Alphapharm search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Alphapharm?

Related Articles

Schock Patents – Insights & Stats (Updated 2024)

Schock has a total of 395 patents globally, out of which 241 have been granted. Of these 395 patents, more than 62% patents are active. Germany is where Schock has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Germany seems to be the main focused

Read More »

Normet Patents – Insights & Stats (Updated 2024)

Normet has a total of 164 patents globally, out of which 121 have been granted. Of these 164 patents, more than 87% patents are active. Europe (EPO) is where Normet has filed the maximum number of patents, followed by Australia and Canada. Parallelly, Finland seems to be the main focused

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.